The Scientific World Journal

The Scientific World Journal / 2014 / Article

Clinical Study | Open Access

Volume 2014 |Article ID 263058 | 5 pages | https://doi.org/10.1155/2014/263058

Oxidant-Antioxidant Balance during On-Pump Coronary Artery Bypass Grafting

Academic Editor: Shahzad G. Raja
Received06 Jun 2014
Accepted22 Jul 2014
Published18 Aug 2014

Abstract

Backround. The aim of this study was to evaluate the changes in perioperative oxidant-antioxidant balance in ONCABG. Methods. Twenty-three patients were included in this study. Serum total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) values were assessed preoperatively, at 20 minutes after aortic clamping and at 30 minutes, 6 hours, and 48 hours after declamping (reperfusion). The patients were divided into 2 groups according to the median aortic cross clamping (XC) time: group 1 (XC time < 42 minutes) and group 2 (XC time ≥ 42 minutes). Results. TOS and OSI values of whole patients at 30 minutes after reperfusion were higher than preoperative values (, ), while perioperative TAS levels of the patients were similar to the preoperative levels (). XC time was correlated with TOS levels at 30 minutes after reperfusion (, ). In group 2, TOS and OSI values at 30 minutes after reperfusion were higher than preoperative values (, ), whereas a significant difference was not found in group 1 (, ). Conclusions. Oxidative imbalance and increase in TOS at reperfusion in ONCABG may be associated with XC time.

1. Introduction

Coronary artery bypass grafting (CABG) induces oxidative stress (OS). This situation is closely associated with overproduction of reactive oxygen species (ROS). ROS plays an important role in the physiopathogenesis of OS [14]. ROS have toxic effects on cell structures including lipids, proteins, and nucleic acids. The oxidative reaction leads injury to cell function and may enhance the perioperative or postoperative complications after CABG [5, 6].

However, ROS that have been considered not only as lethal byproducts of cellular metabolism but also as important molecules in vascular signaling are normally present in cells. The production of ROS in the organisms and their degradation by antioxidants is in balance. When ROS exceeds the antioxidant capacity, this situation results in OS [3, 5, 7]. Thus, evaluation of oxidants and antioxidants together in patients undergoing CABG may yield a more objective view about the change in the oxidative balance.

Serum concentrations of different oxidative components can be measured in the laboratory separately, but the measurement of these molecules is labor intensive and requires much time, complicated techniques, and cost. Total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) reflect the redox balance between oxidation and antioxidation. TAS measurement is an indicatorof the activity of all antioxidants while TOS is anindicator of ROS. OSI is the ratio of TOS to TAS and an indicator of OS degree [8, 9].

There are various obstacles to devise appropriate strategies for optimal perioperative antioxidant therapy. Contribution of the various mechanisms on the oxidant-antioxidant balance during on-pump coronary artery bypass grafting (ONCABG) has not been fully evaluated yet [2, 4]. In this study, we have evaluated the changes in oxidant-antioxidant balance and its relation to XC time by measuring TOS, TAS and calculating OSI in ONCABG patients.

2. Materials and Methods

2.1. Study Population

A total of 23 patients (17 males, 6 females) who underwent elective isolated ONCABG were included in this study. Patients with any of the following criteria were excluded: acute coronary syndrome, emergency surgery, reoperation, combined procedures (e.g., valvular surgery), off-pump coronary artery bypass grafting (OPCAB), as well as patients with chronic inflammatory disease (such as rheumatoid arthritis, malignancy, or psoriasis), with autoimmune disease, or receiving immunosuppressive drugs. None of the patients used vitamins or dietary supplements. Informed consent was obtained from all patients, and approval for the study was given by the local ethics committee (2013-164).

The median aortic cross clamping (XC) time was 42 minutes. We divided the patients into 2 groups according to median XC time. Group 1 consists of 11 patients (8 males, 3 females) with a below median XC time and group 2 consists of 12 patients (9 males, 3 females) with a median and above median XC time.

2.2. Surgical Technique

The same surgical and anesthetic team managed all patients. Patients received premedication with midazolam. Anesthesia was induced with midazolam, fentanyl, thiopental, and rocuronium, while sevoflurane and fentanyl were used as maintenance. Radial and pulmonary arterial catheters were introduced under local anesthesia. After standard general anesthesia, a median sternotomy was performed, followed by routine aortic and right atrial cannulation. Cardiopulmonary bypass (CPB) was carried out using membrane oxygenators and moderate systemic hypothermia. Myocardial protection was achieved by antegrade mild hypothermic (32°C) blood cardioplegia, repeated every 20 min. Heparin 3.0 mg/kg was administered, and the activated clotting time was maintained >400 sec during the procedure. Heparin was neutralized with protamine in a ratio of 1 : 1.3 within 10 minutes after the end of CPB. After surgery, all patients were followed up in the intensive care unit.

2.3. Sample Collection

Blood samples for TOS and TAS determination were drawn preoperatively, 20 minutes after aortic cross clamping and just before the administration of the second cardioplegia (AC 20 min), and 30 minutes (Rp 30 min), 6 hours (Rp 6 h), and 48 hours (Rp 48 h) after cross clamp release (reperfusion) from the arterial line. The blood samples were kept at room temperature for 30 minutes and then separated from the cells by centrifugation at 3000 rpm for 5 minutes. Serum samples were stored at −80°C until the day of biochemical analysis.

2.4. Biochemical Assays
2.4.1. Measurement of Total Oxidant Status (TOS)

TOS levels were determined using a method previously described by Erel [9] and calculated in μmol H2O2 equivalent/L.

2.4.2. Measurement of Total Antioxidant Status (TAS)

TAS levels were determined using a method developed by Erel [10] and calculated in mmol Trolox equivalent/L.

2.4.3. Calculation of Oxidative Stress Index (OSI)

The TOS : TAS ratio was used as OSI. To perform the calculation, the unit of TAS, mmol Trolox equivalent/L, was converted to μmol Trolox equivalent/L, and OSI was calculated as follows: OSI = [(TOS, μmol H2O2 equivalent/L)/(TAS, μmol Trolox equivalent/L) × 100].

2.5. Statistical Analysis

Descriptive statistics for the studied variables (characteristics) were presented as Mean ± Standard Deviation. Two-factor experiment with repeated measures on one factor analysis of variance was used to compare the groups and periods for TAS, TOS, and OSI. Following analysis of variance, Tukey’s multiple comparison test was performed to determine different periods. In addition, Student’s t-test was executed to compare groups in terms of other characteristics. For determining the relationships between the characteristics, Spearman’s correlation coefficient was calculated, and for determining the relationships between groups and categorical variables, chi-square test was performed. Statistical significance levels were considered as and SPSS (version 13) statistical program was used for all statistical computations.

3. Results

Groups were similar in terms of age, gender, and BSA. The demographic characteristics of the patients are presented in Table 1. The mean cross clamping time was minutes ( minutes in group 1 and minutes in group 2). There was no in-hospital mortality, severe cardiopulmonary, or vascular morbidity. Perioperative variables of the patients are presented in Table 2.


Whole patients ()Group 1 ()Group 2 () value*

Age, year62.87 ± 10.31063.64 ± 8.58262.17 ± 12.0210.741
Male, (%)17 (73.9%)8 (72.7%)9 (75.0%)0.901
BSA (m2)1.838 ± 0.1751.848 ± 0.1931.828 ± 0.1650.793
Urea (mg/dL)38.13 ± 10.38535.91 ± 13.21740.17 ± 6.8870.338
Creatinine (mg/dL)0.939 ± 0.2820.918 ± 0.2990.958 ± 0.2780.742
ALT (U/L)28.57 ± 18.57122.64 ± 10.85634.00 ± 22.700 0.147
AST (U/L)32.96 ± 18.82635.09 ± 22.17031.00 ± 15.9150.614
ACE inhibitors, (%)11 (47.8%)4 (36.4%)7 (58.3%)0.292
Calcium antagonists, (%)1 (4.3%)0 (0%)1 (8.3%)0.328
Beta blockers, (%)4 (17.4%)2 (18.2%)2 (16.7%)0.924
Nitrates, (%)5 (21.7%)2 (18.2%)3 (25.0%)0.692
HT, (%)17 (73.9%)7 (63.6%)10 (83.3%)0.283
DM, (%)5 (21.7%)2 (18.2%)3 (25.0%)0.692
COPD, (%)3 (13.0%)2 (18.2%)1 (8.3%)0.484
PAD, (%)2 (8.7%)1 (9.1%)1 (8.3%)0.949
CVD, (%)1 (4.3%)0 (0%)1 (8.3%)0.328
Smoking, (%)7 (30.4%)2 (18.2%)5 (41.7%)0.221
Alcohol, (%)1 (4.5%)1 (9.1%)0 (0%)0.306
CCS class2.26 ± 0.4492.36 ± 0.5052.17 ± 0.3890.304
LVEF53.48 ± 9.22452.27 ± 8.47554.58 ± 10.1040.561
LMCAD1 (4.3%)0 (0%)1 (8.3%)0.328

*Comparison of group 1 and group 2.
ACE: angiotensin converting enzyme, ALT: alanine aminotransferase, AST: aspartate aminotransferase, BSA: body surface area, CCS: Canadian Cardiovascular Society, COPD: chronic obstructive pulmonary disease, CVD: cerebrovascular disease, DM: diabetes mellitus, HT: hypertension, LMCAD: left main coronary artery disease, LVEF: left ventricular ejection fraction, and PAD: peripheral arterial disease.

Whole patients () Group 1 ()Group 2 () value*

Number of grafts2.913 ± 0.9962.636 ± 0.8093.167 ± 1.1150.209
LIMA use, (%)20 (87%)10 (90.9%)10 (83.3%)0.590
ACC time (min)44.87 ± 19.21229.18 ± 9.50659.25 ± 13.5790.001
CPB time (min)98.43 ± 32.48175.64 ± 21.463119.33 ± 26.3620.001
Aerobic pump time (min)53.57 ± 20.27346.45 ± 20.44760.08 ± 18.5740.109
Ventilation time (h)8.22 ± 2.8647.86 ± 1.9518.54 ± 3.5640.583
ICU stay (h)31.87 ± 15.25628.64 ± 15.82634.83 ± 14.7580.342
Hospital stay (day)5.61 ± 0.7835.64 ± 0.9245.58 ± 0.6690.875

*Comparison of group 1 and group 2.
ACC: aortic crossclamp, CPB: cardiopulmonary bypass, h: hours, ICU: intensive care unit, LIMA: left internal mammary artery, and min: minutes.

When all cases of ONCABG were evaluated, the TOS and OSI values of Rp 30 min were significantly higher than the preoperative TOS and OSI values (, , resp.), while perioperative TAS levels of the patients were similar with the preoperative TAS levels (). There was a positive correlation between cross clamping time and TOS levels at Rp 30 min (, ).

In group 2 TOS and OSI values at Rp 30 min were significantly higher than the preoperative values (, , resp.), while perioperative TOS and OSI values of group 1 were similar to the preoperative values (, , resp.). TOS, TAS, and OSI values of the patients are presented in Table 3.


Whole patients ()Group 1 ()Group 2 ()

TOS levels (mol H2O2 equivalent/L.)
 Preoperative10.14 ± 7.689.53 ± 8.0810.69 ± 7.65
 AC 20 min 8.81 ± 3.578.88 ± 4.208.76 ± 3.23
 Rp 30 min12.47 ± 6.41a9.83 ± 3.1015.12 ± 7.82d
 Rp 6 h11.72 ± 6.609.06 ± 3.3514.16 ± 7.96e
 Rp 48 h8.79 ± 2.837.86 ± 1.5510.08 ± 3.73
TAS levels (mmol Trolox equivalent/L)
 Preoperative1.91 ± 0.311.98 ± 0.371.86 ± 0.25
 AC 20 min1.83 ± 0.241.83 ± 0.201.82 ± 0.29
 Rp 30 min1.79 ± 0.261.74 ± 0.26c1.83 ± 0.27
 Rp 6 h1.92 ± 0.281.82 ± 0.212.01 ± 0.31
 Rp 48 h1.87 ± 0.241.78 ± 0.171.98 ± 0.28
OSI values [(mol H2O2 equivalent/L)/mol Trolox equivalent/L) × 100]
 Preoperative0.54 ± 0.390.45 ± 0.260.61 ± 0.49
 AC 20 min0.48 ± 0.170.49 ± 0.220.47 ± 0.12f
 Rp 30 min0.70 ± 0.36b0.57 ± 0.190.83 ± 0.44g
 Rp 6 h0.61 ± 0.320.50 ± 0.180.70 ± 0.40
 Rp 48 h0.46 ± 0.130.44 ± 0.090.49 ± 0.17

aWhen compared to preoperative value .
bWhen compared to preoperative value .
cWhen compared to preoperative value .
dWhen compared to preoperative value .
eWhen compared to preoperative value .
fWhen compared to preoperative value .
gWhen compared to preoperative value .

4. Discussion

We found that the patients undergoing ONCABG are exposed to potent oxidative imbalance and increase in oxidants at reperfusion which are associated with duration of XC.

CABG procedure induces overproduction of ROS (hydroxyl, hydrogen peroxide, hypochlorite, and superoxide) which originates from various enzymatic and cellular sources [1, 3, 4]. Determining TOS is more practical than individual ROS measurements [9]. In the present study, the significant increase in TOS levels at Rp 30 min shows an increase in ROS production in ONCABG patients.

On the other hand, controversial findings were reported on the perioperative course of antioxidants in CABG patients [3, 4, 6, 11, 12]. The effects of antioxidant molecules in serum are additive. The cooperation of antioxidants in serum provides protection for the organism against ROS. The real antioxidant status of the organism may not be reflected by individual measurement of antioxidants. Measurement of TAS ought to be essential in evaluation of the real antioxidant status [8, 9, 13]. In the present study, perioperative TAS levels of patients were similar to the basal levels.

Oxidative stress is an oxidant-antioxidant imbalance status, due to oxidants which exceed the antioxidant capacity. OSI is the ratio of TOS to TAS and is an indicator of OS degree [8, 9, 13]. It may offer a more accurate comment for the evaluation of the change in oxidant-antioxidant balance. In the present study, we found significant increase of OSI values at Rp 30 min. This finding suggested the development of oxidative imbalance or increase in the degree of OS in ONCABG patients.

In ONCABG patients there are many causes of oxidative stress such as surgical damage, CPB, and ischemia reperfusion injury [4, 6, 14]. In our study, we aimed to detect a different finding in terms of assessment of oxidant-antioxidant balance, in the ischemia period (AC 20 min), and also tried to distinguish the effect of reperfusion. If blood samples for the ischemia period were taken just before aortic cross clamping was removed, the effects of ischemia as well as the effects of reperfusion due to the cardioplegias could have occurred [6]. Some of the surgical manipulations had been done and CPB had started before this part of the intervention (AC 20 min) as well. The presence of an increase in TOS and OSI at Rp 30 min, with absence of an increase at AC 20 min, suggests that reperfusion may be a major inducer of oxidative imbalance in ONCABG.

Ischemic period associated with oxidative stress in CABG. Authors reported that XC time was correlated with total peroxide, 8-isoprostane, and nitrites/nitrates levels in patients undergoing CABG [15, 16]. We also detected a positive correlation between XC time and TOS levels at Rp 30 min.

Ferrari et al. reported a significant and sustained increase in OS in 10 patients undergoing ONCABG with a mean XC duration of 55.2 minutes, while a mild and temporary increase in OS in 10 patients undergoing ONCABG with a mean XC duration of 25.2 minutes [17]. Nowicki et al. also reported the absence of a significant oxidative damage in the myocardial biopsy specimens of 8 patients undergoing ONCABG with a mean XC duration of 29.5 minutes [18]. To our knowledge, this paper is the first in the literature which reported neither systemic oxidant increase nor systemic oxidative imbalance occurred in patients with a mean XC duration of 29 minutes (group 1) by evaluating TOS and OSI. On the contrary, significant systemic oxidant increase and systemic oxidative imbalance were observed in group 2. The increase in TOS and OSI values of whole patients was mostly affected by the increase in TOS and OSI values of patients in group 2.

The oxidative balance change which was more significant at group 2 might be affected from demographic data of patients. The relation between HT and smoking with oxidative balance changes has been reported previously [19, 20]. In our study this parameters’ statistical similarity might be caused by the fewness of patients. Besides, similarity of demographic characteristics of dispersed patients into groups may enable us to isolate XC time effect on TOS, TAS, and OSI from the other potential effective statuses like HT, smoking, any drug utilizations, and so forth.

The CPB duration of the groups was also different. But there was no difference in terms of aerobic pump times. Prolongation of CPB time in group 2 was mainly due to longer length of XC duration.

Clinical trials conducted with a variety of antioxidant strategies have been largely disappointing. Optimal design of antioxidant strategies in patients undergoing ONCABG needs detailed evaluation of oxidative phenomenon [2, 6]. In our study, the oxidant-antioxidant balance was not affected in ONCABG patients with a short XC duration, so we believe that widespread antioxidant therapy may not be needed. Administration of antioxidants in selected cases may be more effective. Studies to determine the critical XC durations in terms of oxidative imbalance may be designed. Further larger-scale prospective studies are required for accurate strategies to this clinical phenomenon.

The major limitation of the current study may be the relatively small number of patients.

5. Conclusions

In conclusion, according to assessments of TAS, TOS, and OSI, an oxidative imbalance or increase in OS degree was observed in patients who underwent ONCABG, especially due to an increase in TOS at reperfusion. Moreover, not only increase in TOS at reperfusion but also oxidative imbalance seems to be associated with XC time. These findings inspire further studies which may provide important criteria for antioxidant therapy.

Conflict of Interests

The authors have no personal relationships with other individuals or organizations that might have inappropriately influenced their work during the submission process.

Acknowledgment

The authors are grateful to Professor Dr. Sıddık Keskin for his assistance in the statistical analysis.

References

  1. G. Orhan, M. Sargin, S. Senay et al., “Systemic and myocardial inflammation in traditional and off-pump cardiac surgery,” Texas Heart Institute Journal, vol. 34, no. 2, pp. 160–165, 2007. View at: Google Scholar
  2. J. Milei, D. R. Grana, P. Forcada, and G. Ambrosio, “Mitochondrial oxidative and structural damage in ischemia-reperfusion in human myocardium. Current knowledge and future directions,” Frontiers in Bioscience, vol. 12, no. 3, pp. 1124–1130, 2007. View at: Publisher Site | Google Scholar
  3. A. J. McColl, T. Keeble, L. Hadjinikolaou et al., “Plasma antioxidants: Evidence for a protective role against reactive oxygen species following cardiac surgery,” Annals of Clinical Biochemistry, vol. 35, no. 5, pp. 616–623, 1998. View at: Publisher Site | Google Scholar
  4. C. R. Luyten, F. J. van Overveld, L. A. de Backer et al., “Antioxidant defence during cardiopulmonary bypass surgery,” European Journal of Cardio-thoracic Surgery, vol. 27, no. 4, pp. 611–616, 2005. View at: Publisher Site | Google Scholar
  5. V. Cavalca, E. Sisillo, F. Veglia et al., “Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery,” Annals of Thoracic Surgery, vol. 81, no. 2, pp. 562–567, 2006. View at: Publisher Site | Google Scholar
  6. J. Milei, P. Forcada, C. G. Fraga et al., “Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion,” Cardiovascular Research, vol. 73, no. 4, pp. 710–719, 2007. View at: Publisher Site | Google Scholar
  7. T. Szasz, K. Thakali, G. D. Fink, and S. W. Watts, “A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease,” Experimental Biology and Medicine, vol. 232, no. 1, pp. 27–37, 2007. View at: Google Scholar
  8. M. Rabus, R. Demirbağ, Y. Sezen et al., “Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease,” Turk Kardiyoloji Dernegi Arsivi, vol. 36, no. 8, pp. 536–540, 2008. View at: Google Scholar
  9. O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–11111, 2005. View at: Publisher Site | Google Scholar
  10. O. Erel, “A novel automated method to measure total antioxidant response against potent free radical reactions,” Clinical Biochemistry, vol. 37, no. 2, pp. 112–119, 2004. View at: Publisher Site | Google Scholar
  11. S. Storti, A. G. Cerillo, A. Rizza et al., “Coronary artery bypass grafting surgery is associated with a marked reduction in serum homocysteine and folate levels in the early postoperative period,” European Journal of Cardio-Thoracic Surgery, vol. 26, no. 4, pp. 682–686, 2004. View at: Publisher Site | Google Scholar
  12. Akila, B. D'souza, P. Vishwanath, and V. D'souza, “Oxidative injury and antioxidants in coronary artery bypass graft surgery: off-pump CABG significantly reduces oxidative stress,” Clinica Chimica Acta, vol. 375, no. 1-2, pp. 147–152, 2007. View at: Publisher Site | Google Scholar
  13. M. Aslan, N. Cosar, H. Celik et al., “Evaluation of oxidative status in patients with hyperthyroidism,” Endocrine, vol. 40, no. 2, pp. 285–289, 2011. View at: Publisher Site | Google Scholar
  14. K. Berg, R. Haaverstad, R. Astudillo et al., “Oxidative stress during coronary artery bypass operations: importance of surgical trauma and drug treatment,” Scandinavian Cardiovascular Journal, vol. 40, no. 5, pp. 291–297, 2006. View at: Publisher Site | Google Scholar
  15. A. S. Kunt, S. Selek, H. Celik, D. Demir, O. Erel, and M. H. Andac, “Decrease of total antioxidant capacity during coronary artery bypass surgery,” Mount Sinai Journal of Medicine, vol. 73, no. 5, pp. 777–783, 2006. View at: Google Scholar
  16. J. García-de-la-Asunción, E. Pastor, J. Perez-Griera et al., “Oxidative stress injury after on-pump cardiac surgery: effects of aortic cross clamp time and type of surgery,” Redox Report: Communications in Free Radical Research, vol. 18, no. 5, pp. 193–199, 2013. View at: Publisher Site | Google Scholar
  17. R. Ferrari, O. Alfieri, S. Curello et al., “Occurrence of oxidative stress during reperfusion of the human heart,” Circulation, vol. 81, no. 1, pp. 201–211, 1990. View at: Publisher Site | Google Scholar
  18. R. Nowicki, J. Saczko, J. Kulbacka et al., “The estimation of oxidative stress markers and apoptosis in right atrium auricles cardiomyocytes of patients undergoing surgical heart revascularisation with the use of warm blood cardioplegia,” Folia Histochemica et Cytobiologica, vol. 48, no. 2, pp. 202–207, 2010. View at: Publisher Site | Google Scholar
  19. D. G. Harrison and M. C. Gongora, “Oxidative stress and hypertension,” Medical Clinics of North America, vol. 93, no. 3, pp. 621–635, 2009. View at: Publisher Site | Google Scholar
  20. M. A. H. Talukder, W. M. Johnson, S. Varadharaj et al., “Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 300, no. 1, pp. H388–H396, 2011. View at: Publisher Site | Google Scholar

Copyright © 2014 Umit Mentese et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

877 Views | 382 Downloads | 13 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.